期刊文献+

体外组装补体膜攻击复合物对肾小管上皮细胞Ⅳ型胶原合成的影响

Effect of membrane attack complex assembling on synthesis of collagen type Ⅳ in renal tubular epithelial cells in vitro
暂未订购
导出
摘要 目的探讨补体膜攻击复合物(membrane attack complex,MAC)对肾小管上皮细胞HK-2细胞外基质成分Ⅳ型胶原表达的影响。方法以纯化的c56及新鲜正常人血清(the normal human serum,NHS)作为C7~C9来源,体外组装sMAC建立HK-2亚溶破模型,通过流式细胞仪检测MAC刺激后的Ⅳ型胶原表达情况,荧光显微镜检测MAC的沉积。结果MAC刺激后的HK-2与对照组比较Ⅳ型胶原和合成增多(P〈0.05)。结论亚溶破剂量的MAC能使HKC的Ⅳ型胶原表达上调,可能是引起肾小管间质纤维化细胞外基质增多的原因之一。 Objective To explore the effect of the membrane attack complex (MAC) on the expression of collagen type Ⅳ in renal tubular epithelial cells (TEC). Methods Purified C56 and C7 ,C8 and C5 come from the normal human serum (NHS) was added to form MAC in vitro, sMAC deposition was identified by immunofluorescence microscope. The expression of collagen type Ⅳ was assayed by FCM. Results Incubation of TEC with MAC increased the expression of collagen type Ⅳ (P〈0.05) in comparison with unstimulated cell. Conclusion MAC can increased the level of collagen type Ⅳ in cultured TEC, it may be among causes of abnormal accumulation extracellular matrix in TEC with tubulointerstitial fibrosis .
出处 《重庆医学》 CAS CSCD 2007年第5期389-390,共2页 Chongqing medicine
基金 国家自然科学基金(30570870) 重庆市自然科学基金资助(CSTC.2005BB5302)
关键词 补体膜攻击复合物 小管间质纤维化 Ⅳ型胶原 membrane attack complex tubulointerstitial fibrosis collagen type Ⅳ
  • 相关文献

参考文献9

  • 1闫振成,张建国.补体攻膜复合物与肾小球疾病[J].重庆医学,2003,32(11):1569-1571. 被引量:3
  • 2Pratt JR,Abe K,Miyazaki M,et al.In situ localization of C3 synthesis in experimental acute renal allograft rejection[J].Am J Pathol,2000,157:825
  • 3Eddy AA.Molecular basis of renal fibrosis[J].Pediatr Nephrol,2000,15(34):290
  • 4袁发焕,张耀全.慢性肾脏病患者肾组织蛋白酶B的表达及意义[J].重庆医学,2003,32(6):656-658. 被引量:2
  • 5Zhou W,Farrar CA,Abe K,et al.Predominant role for C5b-9 in renal ischemia/reperfusion injury[J].J Clin Invest,2000,105:1363
  • 6Kemper C,Chan AC,Green JM,et al.Activation of human CD4 cells with CD3 and CD46 inducesa T-regulatory cell 1 phenotype[J].Nature,2003,421:388
  • 7Ke LI,Hetal,Patel,et al.Complement Activation Regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response[J].J Am Soc Nephrol,2004,15:2414
  • 8ThirumaV,Arumugan,LanAShiels.A small molecule C5 a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats[J].Kidney Int,2003,63(1):1523
  • 9Schiller B,Cunningham PN,Alexander JJ,et al.Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure[J].J Am Soc Nephrol,2001,12(1):71

二级参考文献25

  • 1Rerolle JP, Hertig A, Nguyen G,et al. Plasminogen activator inhibitor type-1 is a potential target in renal fibrogenesis[J]. Kidney Int, 2000,58 : 1841.
  • 2Kazes J, Delarue F, Hagege J,et al. Soluble latent membrancetype 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase[J]. Kidney Int,1998,54:1976.
  • 3Levicar N,Kos J,Blejec A,et al. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients[J]. Cancer Detect Prev, 2002,26 ( 1 ) : 42.
  • 4Koblinski JE, Dosescu J, Sameni M, et al. Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B[J]. J Biol Chem , 2002,277 (35)32220.
  • 5Sinha AA,Jamuar MP,Wilson MJ, et al. Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis[J]. Prostate, 2001,49(3) : 172.
  • 6Sadaki Y, Hiroshi T, Keitaro K. Immunocytochemical localization of cathepsin B in rat kidney: light microscopic study using the indirect immunoenzyme technique[J]. J Histochem Cytochem, 1986, 34(7) :891.
  • 7Ake K, Miyazaki M, Koj i T, et al. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy[J]. Nephron,2001,87(3) :231.
  • 8van Dixhoorn MG, Sato J, Muizert Y, et al. Combined glomerular deposition of polymeric rat IgA and IgG aggravates renal inflammation[J]. Kidney Int, 2000,58( 1 ) :90.
  • 9Csipo P. Serum complement activation of SLE patients during plasmapheresis [J]. Autoimmunity, 1997,25 ( 3 ):139.
  • 10Teixeira JE,Costa RS, Lachmann, et al. CR1 stump peptide and terminal complement complexes are found in glomeruli of lupus nephritis patients[J]. Clin Exp Immunol,1996,105(3) :497.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部